FIBROSIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR SPHINGOSINE-1-PHOSPHATE

摘要

Fibrosis inhibitors containing as the active ingredient a sphingosine-1-phosphate (S1P) receptor agonist or sphingosine-1-phosphate (S1P). Because of having an effect of inhibiting fibrosis in various organs, S1P receptor agonists (in particular, S1P) are useful in preventing and/or treating diseases in association with fibrosis of organs such as pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, hepatic cirrhosis, chronic renal insufficiency or kidney glomerular sclerosis.